EE200000617A - Kontrollitud vabanemisega levosimendani peroraalsed koostised - Google Patents

Kontrollitud vabanemisega levosimendani peroraalsed koostised

Info

Publication number
EE200000617A
EE200000617A EEP200000617A EEP200000617A EE200000617A EE 200000617 A EE200000617 A EE 200000617A EE P200000617 A EEP200000617 A EE P200000617A EE P200000617 A EEP200000617 A EE P200000617A EE 200000617 A EE200000617 A EE 200000617A
Authority
EE
Estonia
Prior art keywords
levosimendan
controlled release
oral formulations
release oral
formulations
Prior art date
Application number
EEP200000617A
Other languages
English (en)
Inventor
Larma Ilkka
B�ckman Maarit
Antila Saila
Lehtonen Lasse
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8551575&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000617(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of EE200000617A publication Critical patent/EE200000617A/et
Publication of EE04220B1 publication Critical patent/EE04220B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
EEP200000617A 1998-04-23 1999-04-23 Kontrollitud vabanemisega levosimendani peroraalsed koostised EE04220B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980901A FI980901A (fi) 1998-04-23 1998-04-23 Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
PCT/FI1999/000329 WO1999055305A2 (en) 1998-04-23 1999-04-23 Controlled release peroral compositions of levosimendan

Publications (2)

Publication Number Publication Date
EE200000617A true EE200000617A (et) 2002-06-17
EE04220B1 EE04220B1 (et) 2004-02-16

Family

ID=8551575

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000617A EE04220B1 (et) 1998-04-23 1999-04-23 Kontrollitud vabanemisega levosimendani peroraalsed koostised

Country Status (38)

Country Link
US (1) US7045147B1 (et)
EP (1) EP1071397B1 (et)
JP (2) JP4566402B2 (et)
KR (1) KR100960597B1 (et)
CN (1) CN1248691C (et)
AR (1) AR019096A1 (et)
AT (1) ATE258425T1 (et)
AU (1) AU756641B2 (et)
BG (1) BG64839B1 (et)
BR (1) BR9909869A (et)
CA (1) CA2329234C (et)
CO (1) CO5070607A1 (et)
CZ (1) CZ295194B6 (et)
DE (1) DE69914472T2 (et)
DK (1) DK1071397T3 (et)
EA (1) EA002829B1 (et)
EE (1) EE04220B1 (et)
ES (1) ES2215379T3 (et)
FI (1) FI980901A (et)
GE (1) GEP20032906B (et)
HK (1) HK1034032A1 (et)
HR (1) HRP20000704B1 (et)
HU (1) HUP0101458A3 (et)
ID (1) ID27987A (et)
IL (2) IL138951A0 (et)
MX (1) MXPA00010367A (et)
NO (1) NO329809B1 (et)
NZ (1) NZ507453A (et)
PL (1) PL197447B1 (et)
PT (1) PT1071397E (et)
RS (1) RS49962B (et)
SI (1) SI1071397T1 (et)
SK (1) SK285427B6 (et)
TR (1) TR200003102T2 (et)
TW (1) TWI224507B (et)
UA (1) UA68376C2 (et)
WO (1) WO1999055305A2 (et)
ZA (1) ZA200005632B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
CA2518734A1 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
AU2009267052B2 (en) 2008-06-30 2013-07-11 Tocagen Inc. Formulations of 5-fluorocytosine and uses thereof
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ203684A (en) 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia

Also Published As

Publication number Publication date
CA2329234C (en) 2008-06-10
NZ507453A (en) 2003-02-28
FI980901A (fi) 1999-10-24
PL344078A1 (en) 2001-09-24
SK285427B6 (sk) 2007-01-04
UA68376C2 (en) 2004-08-16
SK15542000A3 (sk) 2001-08-06
ES2215379T3 (es) 2004-10-01
TR200003102T2 (tr) 2001-02-21
GEP20032906B (en) 2003-02-25
BG64839B1 (bg) 2006-06-30
EP1071397A2 (en) 2001-01-31
DE69914472D1 (de) 2004-03-04
BG104959A (en) 2001-07-31
ATE258425T1 (de) 2004-02-15
MXPA00010367A (es) 2002-06-04
AU756641B2 (en) 2003-01-16
IL138951A0 (en) 2001-11-25
CN1301163A (zh) 2001-06-27
NO329809B1 (no) 2010-12-20
YU63900A (sh) 2003-07-07
TWI224507B (en) 2004-12-01
HUP0101458A2 (hu) 2002-03-28
US7045147B1 (en) 2006-05-16
CO5070607A1 (es) 2001-08-28
ID27987A (id) 2001-05-03
HUP0101458A3 (en) 2002-05-28
WO1999055305A3 (en) 1999-12-29
KR100960597B1 (ko) 2010-06-07
IL138951A (en) 2006-10-31
ZA200005632B (en) 2002-01-14
PL197447B1 (pl) 2008-03-31
SI1071397T1 (en) 2004-06-30
DK1071397T3 (da) 2004-04-05
HK1034032A1 (en) 2001-10-12
CZ295194B6 (cs) 2005-06-15
AR019096A1 (es) 2001-12-26
CZ20003780A3 (en) 2001-05-16
JP2002512946A (ja) 2002-05-08
EA200001098A1 (ru) 2001-04-23
CA2329234A1 (en) 1999-11-04
NO20005313D0 (no) 2000-10-20
NO20005313L (no) 2000-11-21
JP2010083900A (ja) 2010-04-15
CN1248691C (zh) 2006-04-05
WO1999055305A2 (en) 1999-11-04
EE04220B1 (et) 2004-02-16
DE69914472T2 (de) 2004-11-11
RS49962B (sr) 2008-09-29
HRP20000704A2 (en) 2001-04-30
HRP20000704B1 (en) 2009-11-30
FI980901A0 (fi) 1998-04-23
BR9909869A (pt) 2000-12-19
PT1071397E (pt) 2004-06-30
KR20010071172A (ko) 2001-07-28
AU3524699A (en) 1999-11-16
JP4566402B2 (ja) 2010-10-20
EP1071397B1 (en) 2004-01-28
EA002829B1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
IS2325B (is) Örgerðar samsetningar epleróns
DK200200116U4 (da) Mundhygiejnepræparat til behandling af halitosis
HUP0103883A3 (en) New sustained release oral formulations
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
DK0973527T3 (da) Clarithromycinformuleringer med forlænget frigivelse
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
DK1109558T3 (da) Ranolazinformuleringer med langvarig frigivelse
DK1140105T3 (da) Galantaminpræparat med styret frigivelse
DE59902843D1 (de) Brauseformulierungen
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
ATE254907T1 (de) Natriumhydrogendivalproat-formulierungen mit gesteuerter freigabe
NO20004240D0 (no) Formuleringer
EE03854B1 (et) Levosimendaani suu kaudu manustatavad segud
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
DK0966299T3 (da) Hidtil ukendte orale formuleringer af calcitonin.
DE19983627T1 (de) Knoblauch-Formulierungen mit kontrollierter Freisetzung
BR9509565A (pt) Composições orais de liberação prolongada de cisaprida
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
EE04220B1 (et) Kontrollitud vabanemisega levosimendani peroraalsed koostised
NO20021452D0 (no) Orale kontrollerte frigivelsesformuleringer
SE9802197D0 (sv) Formulations of busulphan
SI1216032T1 (sl) Oralne formulacije s kontroliranim sproščanjem
IT1305311B1 (it) Mezzi di fissaggio di protesi dentarie.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110423